{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:36:37Z","timestamp":1787495797631,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T00:00:00Z","timestamp":1767398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":31,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Med Res"],"DOI":"10.1186\/s40001-025-03745-3","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T02:16:12Z","timestamp":1767492972000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["U-shaped association between TC\/HDL-C ratio and the risk of metabolic dysfunction-associated fatty liver disease in older adults"],"prefix":"10.1186","volume":"31","author":[{"given":"Jie","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,3]]},"reference":[{"key":"3745_CR1","doi-asserted-by":"publisher","first-page":"1565298","DOI":"10.3389\/fcimb.2025.1565298","volume":"15","author":"X Chen","year":"2025","unstructured":"Chen X, et al. Overweight and Helicobacter pylori infection: a correlation in metabolic dysfunction-associated fatty liver disease. Front Cell Infect Microbiol. 2025;15:1565298.","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"3745_CR2","first-page":"174","volume":"11","author":"J Ji","year":"2023","unstructured":"Ji J, et al. The gut microbiome and ferroptosis in MAFLD. J Clin Transl Hepatol. 2023;11(1):174\u201387.","journal-title":"J Clin Transl Hepatol"},{"issue":"2","key":"3745_CR3","doi-asserted-by":"publisher","first-page":"e010841","DOI":"10.1161\/CIRCHEARTFAILURE.123.010841","volume":"17","author":"S Wu","year":"2024","unstructured":"Wu S, et al. Sex and age differences in the association between metabolic dysfunction-associated fatty liver disease and heart failure: a prospective cohort study. Circ Heart Fail. 2024;17(2):e010841.","journal-title":"Circ Heart Fail"},{"issue":"10","key":"3745_CR4","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00535-023-02021-7","volume":"58","author":"H Crane","year":"2023","unstructured":"Crane H, et al. MAFLD: an optimal framework for understanding liver cancer phenotypes. J Gastroenterol. 2023;58(10):947\u201364.","journal-title":"J Gastroenterol"},{"issue":"9","key":"3745_CR5","doi-asserted-by":"publisher","first-page":"100810","DOI":"10.1016\/j.jhepr.2023.100810","volume":"5","author":"BG Song","year":"2023","unstructured":"Song BG, et al. Metabolic dysfunction-associated fatty liver disease and the risk of hepatocellular carcinoma. JHEP Rep. 2023;5(9):100810.","journal-title":"JHEP Rep"},{"issue":"12","key":"3745_CR6","doi-asserted-by":"publisher","first-page":"4181","DOI":"10.3390\/jcm14124181","volume":"14","author":"M Szymala-Pedzik","year":"2025","unstructured":"Szymala-Pedzik M, et al. MAFLD as a cardiovascular risk factor: an extended retrospective study with a control group. J Clin Med. 2025;14(12):4181.","journal-title":"J Clin Med"},{"issue":"2","key":"3745_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.hbpd.2022.01.006","volume":"21","author":"J Zeng","year":"2022","unstructured":"Zeng J, et al. Prevalence and characteristics of MAFLD in Chinese adults aged 40 years or older: a community-based study. Hepatobiliary Pancreat Dis Int. 2022;21(2):154\u201361.","journal-title":"Hepatobiliary Pancreat Dis Int"},{"issue":"1","key":"3745_CR8","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s12072-022-10436-2","volume":"17","author":"AD Dao","year":"2023","unstructured":"Dao AD, et al. Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States. Hepatol Int. 2023;17(1):225\u201336.","journal-title":"Hepatol Int"},{"issue":"1","key":"3745_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12944-022-01661-7","volume":"21","author":"Z Liu","year":"2022","unstructured":"Liu Z, et al. Comparison of the diagnostic value between triglyceride-glucose index and triglyceride to high-density lipoprotein cholesterol ratio in metabolic-associated fatty liver disease patients: a retrospective cross-sectional study. Lipids Health Dis. 2022;21(1):55.","journal-title":"Lipids Health Dis"},{"key":"3745_CR10","doi-asserted-by":"publisher","first-page":"1405828","DOI":"10.3389\/fendo.2024.1405828","volume":"15","author":"Y Chen","year":"2024","unstructured":"Chen Y, et al. Elevated AIP is associated with the prevalence of MAFLD in the US adults: evidence from NHANES 2017-2018. Front Endocrinol (Lausanne). 2024;15:1405828.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3745_CR11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12876-024-03471-w","volume":"24","author":"X Ma","year":"2024","unstructured":"Ma X, et al. Association between the triglyceride to high density lipoprotein cholesterol ratio and the incidence of metabolic dysfunction-associated fatty liver disease: a retrospective cohort study. BMC Gastroenterol. 2024;24(1):389.","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 2","key":"3745_CR12","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12072-024-10698-y","volume":"18","author":"R Gish","year":"2024","unstructured":"Gish R, et al. Review of current and new drugs for the treatment of metabolic-associated fatty liver disease. Hepatol Int. 2024;18(Suppl 2):977\u201389.","journal-title":"Hepatol Int"},{"key":"3745_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/metabo14030169","author":"R Choi","year":"2024","unstructured":"Choi R, Lee SG, Lee EH. Effect of adding apolipoprotein B testing on the prevalence of dyslipidemia and risk of cardiovascular disease in the Korean adult population. Metabolites. 2024. https:\/\/doi.org\/10.3390\/metabo14030169.","journal-title":"Metabolites"},{"issue":"1","key":"3745_CR14","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s12944-018-0800-y","volume":"17","author":"C Chi","year":"2018","unstructured":"Chi C, et al. Comparison of various lipid parameters in association of target organ damage: a cohort study. Lipids Health Dis. 2018;17(1):199.","journal-title":"Lipids Health Dis"},{"key":"3745_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/nu15183970","author":"K Yang","year":"2023","unstructured":"Yang K, Song M. New insights into the pathogenesis of metabolic-associated fatty liver disease (MAFLD): gut-liver-heart crosstalk. Nutrients. 2023. https:\/\/doi.org\/10.3390\/nu15183970.","journal-title":"Nutrients"},{"key":"3745_CR16","doi-asserted-by":"publisher","first-page":"101833","DOI":"10.1016\/j.arr.2022.101833","volume":"84","author":"Y He","year":"2023","unstructured":"He Y, et al. Emerging role of aging in the progression of NAFLD to HCC. Ageing Res Rev. 2023;84:101833.","journal-title":"Ageing Res Rev"},{"issue":"10","key":"3745_CR17","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/apt.17714","volume":"58","author":"P Danpanichkul","year":"2023","unstructured":"Danpanichkul P, et al. The silent burden of non-alcoholic fatty liver disease in the elderly: a global burden of disease analysis. Aliment Pharmacol Ther. 2023;58(10):1062\u201374.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"3745_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/MOL.0000000000000933","volume":"35","author":"C Foster","year":"2024","unstructured":"Foster C, Gagnon CA, Ashraf AP. Altered lipid metabolism and the development of metabolic-associated fatty liver disease. Curr Opin Lipidol. 2024;35(4):200\u20137.","journal-title":"Curr Opin Lipidol"},{"issue":"7","key":"3745_CR19","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1161\/CIRCULATIONAHA.114.010001","volume":"130","author":"B Doran","year":"2014","unstructured":"Doran B, et al. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III). Circulation. 2014;130(7):546\u201353.","journal-title":"Circulation"},{"issue":"21","key":"3745_CR20","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1161\/CIRCULATIONAHA.117.032321","volume":"137","author":"EM Bucholz","year":"2018","unstructured":"Bucholz EM, et al. Prevalence and predictors of cholesterol screening, awareness, and statin treatment among US adults with familial hypercholesterolemia or other forms of severe dyslipidemia (1999\u20132014). Circulation. 2018;137(21):2218\u201330.","journal-title":"Circulation"},{"issue":"1","key":"3745_CR21","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73(1):202\u20139.","journal-title":"J Hepatol"},{"issue":"8","key":"3745_CR22","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1161\/HYPERTENSIONAHA.122.20678","volume":"80","author":"I Hwang","year":"2023","unstructured":"Hwang I, et al. Rate of change in 10-year atherosclerotic cardiovascular disease risk and its implications for primary prevention. Hypertension. 2023;80(8):1697\u2013706.","journal-title":"Hypertension"},{"issue":"10","key":"3745_CR23","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1016\/S1473-3099(16)30082-2","volume":"16","author":"EJA Fitchett","year":"2016","unstructured":"Fitchett EJA, et al. Strengthening the reporting of observational studies in epidemiology for newborn infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research. Lancet Infect Dis. 2016;16(10):e202\u201313.","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"3745_CR24","first-page":"30","volume":"4","author":"Z Zhang","year":"2016","unstructured":"Zhang Z. Multiple imputation with multivariate imputation by chained equation (MICE) package. Ann Transl Med. 2016;4(2):30.","journal-title":"Ann Transl Med"},{"issue":"1","key":"3745_CR25","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","volume":"42","author":"G Bedogni","year":"2005","unstructured":"Bedogni G, et al. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology. 2005;42(1):44\u201352.","journal-title":"Hepatology"},{"issue":"8","key":"3745_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1111\/j.1572-0241.2004.30159.x","volume":"99","author":"N Chalasani","year":"2004","unstructured":"Chalasani N, Deeg MA, Crabb DW. Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2004;99(8):1497\u2013502.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"3745_CR27","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12944-022-01712-z","volume":"21","author":"S Lu","year":"2022","unstructured":"Lu S, et al. Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population. Lipids Health Dis. 2022;21(1):95.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3745_CR28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1186\/s12876-021-02072-1","volume":"21","author":"J Wang","year":"2021","unstructured":"Wang J, et al. Comparison of several blood lipid-related indexes in the screening of non-alcoholic fatty liver disease in women: a cross-sectional study in the Pearl River Delta region of southern China. BMC Gastroenterol. 2021;21(1):482.","journal-title":"BMC Gastroenterol"},{"key":"3745_CR29","doi-asserted-by":"publisher","DOI":"10.1177\/00033197251345865","author":"T Liu","year":"2025","unstructured":"Liu T, et al. Relationship between total cholesterol\/high-density lipoprotein cholesterol and carotid artery plaque in ischemic stroke patients based on sex and age. Angiology. 2025. https:\/\/doi.org\/10.1177\/00033197251345865.","journal-title":"Angiology"},{"issue":"1","key":"3745_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12944-019-0984-9","volume":"18","author":"XY Ren","year":"2019","unstructured":"Ren XY, et al. Total cholesterol to high-density lipoprotein cholesterol ratio is a significant predictor of nonalcoholic fatty liver: Jinchang cohort study. Lipids Health Dis. 2019;18(1):47.","journal-title":"Lipids Health Dis"},{"issue":"4","key":"3745_CR31","doi-asserted-by":"publisher","first-page":"640","DOI":"10.3390\/cells12040640","volume":"12","author":"CA Yao","year":"2023","unstructured":"Yao CA, Yen TY, Hsu SH, Su TC. Glycative stress, glycated hemoglobin, and atherogenic dyslipidemia in patients with hyperlipidemia. Cells. 2023;12(4):640.","journal-title":"Cells"},{"issue":"1","key":"3745_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13098-024-01457-y","volume":"16","author":"M Zhang","year":"2024","unstructured":"Zhang M, et al. High-density lipoprotein cholesterol trajectory and new-onset metabolic dysfunction-associated fatty liver disease incidence: a longitudinal study. Diabetol Metab Syndr. 2024;16(1):223.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3745_CR33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12944-018-0828-z","volume":"17","author":"T Wu","year":"2018","unstructured":"Wu T, et al. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197.","journal-title":"Lipids Health Dis"},{"issue":"9","key":"3745_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100836","volume":"5","author":"Y Cheng","year":"2023","unstructured":"Cheng Y, et al. Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease. JHEP Rep. 2023;5(9):100836.","journal-title":"JHEP Rep"},{"issue":"8","key":"3745_CR35","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11906-023-01242-8","volume":"25","author":"OO Badmus","year":"2023","unstructured":"Badmus OO, Hinds TDJ, Stec DE. Mechanisms linking metabolic-associated fatty liver disease (MAFLD) to cardiovascular disease. Curr Hypertens Rep. 2023;25(8):151\u201362.","journal-title":"Curr Hypertens Rep"},{"key":"3745_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111629","author":"J Gutierrez-Cuevas","year":"2021","unstructured":"Gutierrez-Cuevas J, Santos A, Armendariz-Borunda J. Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms222111629.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3745_CR37","doi-asserted-by":"publisher","first-page":"9084","DOI":"10.3390\/cimb45110570","volume":"45","author":"M Veskovic","year":"2023","unstructured":"Veskovic M, et al. The interconnection between hepatic insulin resistance and metabolic dysfunction-associated steatotic liver disease-the transition from an adipocentric to liver-centric approach. Curr Issues Mol Biol. 2023;45(11):9084\u2013102.","journal-title":"Curr Issues Mol Biol"},{"key":"3745_CR38","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2024-004514","author":"X Lei","year":"2024","unstructured":"Lei X, et al. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus. BMJ Open Diabetes Res Care. 2024. https:\/\/doi.org\/10.1136\/bmjdrc-2024-004514.","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"1","key":"3745_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1159\/000535524","volume":"16","author":"G Ren","year":"2024","unstructured":"Ren G, et al. Mechanisms and therapeutic strategies for MAFLD targeting TLR4 signaling pathways. J Innate Immun. 2024;16(1):45\u201355.","journal-title":"J Innate Immun"},{"issue":"1","key":"3745_CR40","doi-asserted-by":"publisher","first-page":"18011","DOI":"10.1038\/s41598-019-54285-w","volume":"9","author":"Y Liu","year":"2019","unstructured":"Liu Y, et al. Association between lipid profiles and presence of carotid plaque. Sci Rep. 2019;9(1):18011.","journal-title":"Sci Rep"},{"key":"3745_CR41","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12986-016-0102-1","volume":"13","author":"Z Ghasemzadeh","year":"2016","unstructured":"Ghasemzadeh Z, et al. Divergent pathway of lipid profile components for cardiovascular disease and mortality events: results of over a decade follow-up among Iranian population. Nutr Metab Lond. 2016;13:43.","journal-title":"Nutr Metab Lond"},{"key":"3745_CR42","doi-asserted-by":"publisher","first-page":"1343853","DOI":"10.3389\/fendo.2024.1343853","volume":"15","author":"X Li","year":"2024","unstructured":"Li X, et al. Relationship of postprandial fibroblast growth factor 21 with lipids, inflammation and metabolic dysfunction-associated fatty liver disease during oral fat tolerance test. Front Endocrinol (Lausanne). 2024;15:1343853.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3745_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41574-021-00584-0","volume":"18","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Ajmera V, Loomba R. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022;18(1):55\u201366.","journal-title":"Nat Rev Endocrinol"}],"container-title":["European Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40001-025-03745-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03745-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40001-025-03745-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T12:06:10Z","timestamp":1770120370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s40001-025-03745-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,3]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3745"],"URL":"https:\/\/doi.org\/10.1186\/s40001-025-03745-3","relation":{},"ISSN":["2047-783X"],"issn-type":[{"value":"2047-783X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,3]]},"assertion":[{"value":"30 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study used publicly available summary data, and ethics approval was not necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"189"}}